It is clear that cytokines related to CAR T cell trafficking, such as CXCL10, which was also identified in our previous publications6,11, are elevated following infusion, although it is impossible to specify that this is directly from CAR T cell engagement with target antigen and that the concentration gradient peaks within the tumor. The gene discussed is CXCL10; the disease is neoplasm.